Q32 Bio (QTTB) Short-term Investments (2017 - 2025)

Q32 Bio has reported Short-term Investments for 9 years, with the latest figure at $19.9 million in Q3 2025.

• For the quarter ending Q3 2025, Short-term Investments changed N/A year-over-year to $19.9 million; the trailing twelve-month figure through Sep 2025 stood at $19.9 million (changed N/A YoY), and the FY2022 full-year result was $141.0 million, up 196.98% from the prior year.
• Short-term Investments for Q3 2025 stood at $19.9 million, up from $10.0 million in the prior quarter.
• The five-year high for Short-term Investments was $157.9 million in Q3 2022, with the low at $8.0 million in Q1 2022.
• Average Short-term Investments over 5 years is $68.7 million, with a median of $62.2 million recorded in 2023.
• Year-over-year, Short-term Investments plunged 90.5% in 2022 and surged 1282.31% in 2023.
• Tracing QTTB's Short-term Investments over 5 years: stood at $47.5 million in 2021, then surged by 196.98% to $141.0 million in 2022, then sank by 47.4% to $74.2 million in 2023, then sank by 86.54% to $10.0 million in 2024, then surged by 99.33% to $19.9 million in 2025.
• The last three Short-term Investments figures came in at $19.9 million (Q3 2025), $10.0 million (Q2 2024), and $19.8 million (Q1 2024), per Business Quant data.

Peer Comparison